KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $11.4 billion.

  • Bristol Myers Squibb's Receivables - Net rose 359.15% to $11.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 billion, marking a year-over-year increase of 359.15%. This contributed to the annual value of $10.7 billion for FY2024, which is 159.33% down from last year.
  • As of Q3 2025, Bristol Myers Squibb's Receivables - Net stood at $11.4 billion, which was up 359.15% from $11.4 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Receivables - Net ranged from a high of $11.4 billion in Q2 2024 and a low of $8.5 billion during Q1 2022
  • Moreover, its 5-year median value for Receivables - Net was $10.1 billion (2023), whereas its average is $10.1 billion.
  • Its Receivables - Net has fluctuated over the past 5 years, first tumbled by 172.06% in 2022, then skyrocketed by 1812.95% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Receivables - Net stood at $9.4 billion in 2021, then grew by 5.52% to $9.9 billion in 2022, then rose by 10.47% to $10.9 billion in 2023, then dropped by 1.59% to $10.7 billion in 2024, then rose by 6.28% to $11.4 billion in 2025.
  • Its Receivables - Net stands at $11.4 billion for Q3 2025, versus $11.4 billion for Q2 2025 and $10.8 billion for Q1 2025.